1. The use of a derivative of 1-aminoalkylcyclohexane selected from neramexane and its pharmaceutically acceptable salts, for the treatment or prevention of inflammatory skin diseases, where the inflammatory skin disease is selected from rosacea, eczema and oily skin. The use according to claim 1, wherein the 1-aminoalkylcyclohexane derivative is neramexane mesylate. The use according to claim 2, wherein neramexane mesylate is administered in the range of about 5 mg to about 150 mg / day, or in the range of about 5 mg to about 100 mg / day, or in the range of about 5 mg to about 75 mg / day. . The use according to claim 2, wherein neramexane mesylate is administered at a dose of about 50 mg / day. The use of claim 2, wherein neramexane mesylate is administered at a dose of about 75 mg / day. The use according to claim 1, wherein the 1-aminoalkylcyclohexane derivative is administered once a day, twice a day, or three times a day. The use according to any one of claims 1 to 6, wherein the 1-aminoalkylcyclohexane derivative is administered in a local preparation. The use of claim 7, wherein the 1-aminoalkylcyclohexane derivative is administered in an amount of from 0.1 to 99% by weight. by weight of the drug. 9. The use according to any one of claims 1 to 6, wherein the 1-aminoalkylcyclohexane derivative is administered in an oral preparation. The use of a 1-aminoalkylcyclohexane derivative selected from neramexane and its pharmaceutically acceptable salts for the manufacture of a medicament for the treatment or prevention of inflammatory skin diseases where the inflammatory skin disease is selected from rosacea, eczema and oily skin. 11. The use of claim 10, wherein the 1-aminoalkylcyclohexane derivative is neramexane mesylate. The use of claim 10, where the drug is made for1. Применение производного 1-аминоалкилциклогексана, выбранного из нерамексана и его фармацевтически приемлемых солей, для лечения или предупреждения воспалительных заболеваний кожи, где воспалител
